Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 151 results:
Author Title Type [ Year] Filters: Author is Mikhailidis, Dimitri P [Clear All Filters]
The effect of statins on semen parameters in patients with hypercholesterolemia: A systematic review..
Andrology. 9(5), 1504-1511.
(2021).
(2020).
Endocrine Disease as a Cause of Cardiovascular Disease: Current Perspectives..
Curr Pharm Des. 26(43), 5547-5550.
(2020). Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia..
Curr Med Res Opin. 1-10.
(2020). Vascular surgical procedures in patients with familial hypercholesterolaemia: is it too late?.
Curr Med Res Opin. 36(8), 1255.
(2020). Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus..
Curr Pharm Des. 25(18), 2051-2059.
(2019). Semaglutide, lipid-lowering drugs, and NAFLD..
Lancet Diabetes Endocrinol. 5(5), 329-330.
(2017).
(2017). High incidence of metabolic syndrome further increases cardiovascular risk in patients with type 2 diabetes. Implications for everyday practice..
J Diabetes Complications. 30(1), 9-11.
(2016). Lipids, Statins and Heart Failure: An Update..
Curr Pharm Des. 22(31), 4796-4806.
(2016). Statins and non-alcoholic steatohepatitis..
J Hepatol. 64(1), 241-2.
(2016). Statins and Type 2 Diabetes Mellitus: An Update After 1 Year..
Curr Pharm Des. 22(18), 2723-5.
(2016). Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update..
World J Gastroenterol. 21(22), 6820-34.
(2015). Contrast-Induced Nephropathy: An "All or None" Phenomenon?.
Angiology. 66(6), 508-13.
(2015). Genetic, epidemiologic and clinical data strongly suggest that fasting or non-fasting triglycerides are independent cardiovascular risk factors..
Curr Med Res Opin. 31(3), 435-8.
(2015). High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus..
J Diabetes Complications. 29(1), 142-5.
(2015). Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome..
World J Gastroenterol. 21(25), 7860-8.
(2015). Short-, mid-, and long-term benefits of peri-procedural high-intensity statin administration in patients undergoing percutaneous coronary intervention..
Curr Med Res Opin. 31(2), 191-5.
(2015). Statin therapy and cardiovascular outcomes after coronary revascularization in the elderly..
Atherosclerosis. 238(2), 182-4.
(2015). Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?.
Expert Opin Pharmacother. 16(10), 1449-61.
(2015). The 2013 American College of Cardiology/American Heart Association guidelines for the treatment of dyslipidemia: mind the gaps!.
Curr Med Res Opin. 30(9), 1701-5.
(2014). Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKI..
Nat Rev Nephrol. 10(1), 8-9.
(2014). Are statins 'IDEAL' for non-alcoholic fatty liver disease?.
Curr Med Res Opin. 30(2), 229-31.
(2014). Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview..
Curr Vasc Pharmacol. 12(4), 627-41.
(2014). Dyslipidaemia in 2013: New statin guidelines and promising novel therapeutics..
Nat Rev Cardiol. 11(2), 72-4.
(2014).